These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8339258

  • 1. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA.
    Cancer Res; 1993 Aug 01; 53(15):3524-9. PubMed ID: 8339258
    [Abstract] [Full Text] [Related]

  • 2. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA.
    Br J Cancer; 1992 Sep 01; 66(3):496-502. PubMed ID: 1520586
    [Abstract] [Full Text] [Related]

  • 3. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR, Quak JJ, Roos JC, van Lingen A, Wilhelm AJ, van Kamp GJ, Huijgens PC, Snow GB, van Dongen GA.
    J Nucl Med; 2000 Dec 01; 41(12):1999-2010. PubMed ID: 11138685
    [Abstract] [Full Text] [Related]

  • 4. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
    Visser GW, Gerretsen M, Herscheid JD, Snow GB, van Dongen G.
    J Nucl Med; 1993 Nov 01; 34(11):1953-63. PubMed ID: 8229241
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB, Visser GW, Klok R, van der Schors R, Snow GB, van Dongen GA.
    J Nucl Med; 1996 Feb 01; 37(2):352-62. PubMed ID: 8667076
    [Abstract] [Full Text] [Related]

  • 6. Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.
    Gerretsen M, Visser GW, Brakenhoff RH, van Walsum M, Snow GB, van Dongen GA.
    Cell Biophys; 1994 Feb 01; 24-25():135-42. PubMed ID: 7736517
    [Abstract] [Full Text] [Related]

  • 7. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.
    Beaumier PL, Venkatesan P, Vanderheyden JL, Burgua WD, Kunz LL, Fritzberg AR, Abrams PG, Morgan AC.
    Cancer Res; 1991 Jan 15; 51(2):676-81. PubMed ID: 1845957
    [Abstract] [Full Text] [Related]

  • 8. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
    van Gog FB, Visser GW, Stroomer JW, Roos JC, Snow GB, van Dongen GA.
    Cancer; 1997 Dec 15; 80(12 Suppl):2360-70. PubMed ID: 9406684
    [Abstract] [Full Text] [Related]

  • 9. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
    Börjesson PK, Postema EJ, Roos JC, Colnot DR, Marres HA, van Schie MH, Stehle G, de Bree R, Snow GB, Oyen WJ, van Dongen GA.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
    [Abstract] [Full Text] [Related]

  • 10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 11. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 12. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G, Booth BJ, Batra SK, Colcher D.
    Clin Cancer Res; 1999 Sep 01; 5(9):2613-9. PubMed ID: 10499640
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A, Stafford N, Rowlinson-Busza G, Stewart JS, Epenetos AA.
    Cancer Res; 1995 Mar 01; 55(5):1060-9. PubMed ID: 7866989
    [Abstract] [Full Text] [Related]

  • 15. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb 01; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 16. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
    Postema EJ, Börjesson PK, Buijs WC, Roos JC, Marres HA, Boerman OC, de Bree R, Lang M, Munzert G, van Dongen GA, Oyen WJ.
    J Nucl Med; 2003 Oct 01; 44(10):1690-9. PubMed ID: 14530488
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.
    Breitz HB, Weiden PL, Vanderheyden JL, Appelbaum JW, Bjorn MJ, Fer MF, Wolf SB, Ratliff BA, Seiler CA, Foisie DC.
    J Nucl Med; 1992 Jun 01; 33(6):1099-109. PubMed ID: 1597723
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.
    Colnot DR, Wilhelm AJ, Cloos J, Roos JC, de Bree R, Quak JJ, Snow GB, van Dongen GA.
    J Nucl Med; 2001 Sep 01; 42(9):1364-7. PubMed ID: 11535726
    [Abstract] [Full Text] [Related]

  • 19. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.